Cargando…
New drugs are not enough-drug repositioning in oncology: An update
Drug repositioning refers to the concept of discovering novel clinical benefits of drugs that are already known for use treating other diseases. The advantages of this are that several important drug characteristics are already established (including efficacy, pharmacokinetics, pharmacodynamics and...
Autores principales: | Armando, Romina Gabriela, Gómez, Diego Luis Mengual, Gomez, Daniel Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010222/ https://www.ncbi.nlm.nih.gov/pubmed/32124955 http://dx.doi.org/10.3892/ijo.2020.4966 |
Ejemplares similares
-
Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment
por: Armando, Romina Gabriela, et al.
Publicado: (2018) -
New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
por: Cruz-Burgos, Marian, et al.
Publicado: (2021) -
Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
por: Oliver, Josidel Conceição, et al.
Publicado: (2022) -
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020) -
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)